Page last updated: 2024-08-24

rutecarpine and Triple Negative Breast Neoplasms

rutecarpine has been researched along with Triple Negative Breast Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Gao, R; He, B; Lei, J; Lei, X; Pan, Y; Wang, Z; Yan, M; Yang, N; Zhang, Z1

Other Studies

1 other study(ies) available for rutecarpine and Triple Negative Breast Neoplasms

ArticleYear
Rutaecarpine induces the differentiation of triple-negative breast cancer cells through inhibiting fumarate hydratase.
    Journal of translational medicine, 2023, 08-18, Volume: 21, Issue:1

    Topics: Animals; Cell Differentiation; Chromatography, Liquid; Disease Models, Animal; Fumarate Hydratase; Humans; Mice; Reactive Oxygen Species; Tandem Mass Spectrometry; Triple Negative Breast Neoplasms

2023